These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 7708693)
1. Iontophoresis for modulation of cardiac drug delivery in dogs. Labhasetwar V; Underwood T; Schwendeman SP; Levy RJ Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2612-6. PubMed ID: 7708693 [TBL] [Abstract][Full Text] [Related]
2. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy. Avitall B; Hare J; Zander G; Bockoff C; Tchou P; Jazayeri M; Akhtar M Circulation; 1992 Apr; 85(4):1582-93. PubMed ID: 1555296 [TBL] [Abstract][Full Text] [Related]
3. Model features of a cardiac iontophoretic drug delivery implant. Schwendeman SP; Labhasetwar V; Levy RJ Pharm Res; 1995 May; 12(5):790-5. PubMed ID: 7479570 [No Abstract] [Full Text] [Related]
4. Combination therapy with mexiletine and sotalol suppresses inherited ventricular arrhythmias in German shepherd dogs better than mexiletine or sotalol monotherapy: a randomized cross-over study. Gelzer AR; Kraus MS; Rishniw M; Hemsley SA; Moïse NS J Vet Cardiol; 2010 Aug; 12(2):93-106. PubMed ID: 20663731 [TBL] [Abstract][Full Text] [Related]
5. The Use of Intravenous Sotalol in Cardiac Arrhythmias. Samanta R; Thiagalingam A; Turner C; Lakkireddy DJ; Kovoor P Heart Lung Circ; 2018 Nov; 27(11):1318-1326. PubMed ID: 29853342 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats. Myburgh DP; Smith R; Diamond TH; Faitelson HL; Sommers DK S Afr Med J; 1983 Feb; 63(8):263-5. PubMed ID: 6337412 [TBL] [Abstract][Full Text] [Related]
7. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle. Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718 [TBL] [Abstract][Full Text] [Related]
8. Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias. Fitton A; Sorkin EM Drugs; 1993 Oct; 46(4):678-719. PubMed ID: 7506652 [TBL] [Abstract][Full Text] [Related]
9. Effects of sotalol in twenty patients with cardiac arrhythmias. Latour Y; Dumont G; Brosseau A; LeLorier J Int J Clin Pharmacol Biopharm; 1977 Jun; 15(6):275-8. PubMed ID: 881280 [TBL] [Abstract][Full Text] [Related]
10. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol. Fiset C; Drolet B; Hamelin BA; Turgeon J J Pharmacol Exp Ther; 1997 Oct; 283(1):148-56. PubMed ID: 9336319 [TBL] [Abstract][Full Text] [Related]
15. Long-term sotalol therapy in patients with ventricular arrhythmias. Mary-Rabine L; Soumagne D; Stiels B Acta Cardiol; 1986; 41(2):89-97. PubMed ID: 2424202 [TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamic, pharmacokinetic and antiarrhythmic properties of d-sotalol, the dextro-isomer of sotalol. Advani SV; Singh BN Drugs; 1995 May; 49(5):664-79. PubMed ID: 7601009 [TBL] [Abstract][Full Text] [Related]
17. Sotalol: a new class III antiarrhythmic agent. Zanetti LA Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605 [TBL] [Abstract][Full Text] [Related]